Abiopharma

News list

Harmon Cyrus 🔴 sold 3.5K shares of Olema Pharmaceuticals, Inc. (OLMA) at $29.12 Transaction Date: Jan 14, 2026 | Filing ID: 000002

Full text

News bot Jan. 29, 2026, 2:26 p.m.
🔍 Harmon Cyrus (Executive)

Company: Olema Pharmaceuticals, Inc. (OLMA)

Report Date: 2026-01-14
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares sold: 3,489
- Total shares held: 117,028
Detailed Transactions and Holdings:
- Sold 3,489 shares of Common Stock at $29.12 per share (Direct)
  Date: 2026-01-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 737,770.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-14 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 117,028.00 | Footnotes: F2
Footnotes:
- F1: The weighted average sale price for the transaction reported was $29.12, and the range of prices were between $29.00 and $29.23. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- F2: The shares are held by the Harmon Family Investors LLC, of which the Reporting Person is the manager.